Use of runx3 and mir-532-5p as cancer markers and...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) A61K 31/7105 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2727195

The invention relates to methods for cancer diagnosis, prognosis, and treatment based on the expression or activity levels of RUNX3 and miR- 532-5p. Also disclosed is a method of reducing the inhibition of RUNX3 by miR-532-5p with an agent that interferes with the interaction between RUNX3 and miR-532-5p transcripts.

La présente invention concerne des procédés de diagnostic, pronostic et traitement du cancer basés sur l'expression ou les niveaux d'activité de RUNX3 et de miR-532-5p. Elle concerne également un procédé permettant de réduire l'inhibition de RUNX3 par miR-532-5p à l'aide d'un agent qui interfère avec l'interaction entre des transcriptions de RUNX3 et de miR-532-5p.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of runx3 and mir-532-5p as cancer markers and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of runx3 and mir-532-5p as cancer markers and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of runx3 and mir-532-5p as cancer markers and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1409522

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.